Login / Signup

Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial. Authors' reply.

Neville D YeomansDavid Yates Graham
Published in: Alimentary pharmacology & therapeutics (2019)
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • anti inflammatory drugs
  • open label